About this event

  • Date and time Tue 26 Feb 2019 from 8:30am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Digital Health

Artificial Intelligence (AI) is heralded as a disruptive technology with the potential to revolutionise many industries including health and social care. But as AI systems get better at sorting data and making predictions, the role of this technology alongside existing models of healthcare remains unclear. Attendees will have the opportunity to hear the latest updates from companies like DeepMind, Ada Health and BenevolentAI 

This event will feature academics, doctors and entrepreneurs at the forefront of AI and healthcare. 

Alongside exciting use-cases of AI in healthcare, the event will also explore the regulatory and ethical implications around implementing this technology into our health service, including a debate on the likely impact of AI in Primary Care.  

As the promise of AI, neural networks and deep learning algorithms grows ever larger, it can be hard to keep up with the pace of technology. This event is for anyone with a desire to better understand where these innovations can provide tangible benefits, and how they might be implemented safely, ethically and effectively.   

Topics include:  

  • The opportunities for AI in primary care 
  • The ethical and regulatory perspectives of AI in healthcare 
  • The use of AI in drug discovery  
  • The application of deep learning to breast cancer screening 

Key speakers

Professor Geraint Rees

Dean, Faculty of Life Sciences, University College London

Ms Eleonora Harwich

Director of Research, Reform

Dr Hugh Harvey

Clinical Director, Kheiron Medical Technologies

Dr Dominic King

Health Lead, DeepMind

Dr Matthew Fenech

Affiliate Consultant, AI in Health, Future Advocacy

Dr Jean Nehme

Co-Founder and Chief Executive Officer, Digital Surgery

Dr Keith Grimes

Clinical Innovation Director, Babylon Health

Professor Martin Marshall

Vice Chair External Affairs, Royal College of General Practitioners

Dr Ian Churcher 

Vice President, Drug Discovery, BenevolentAI

Dr Adel Baluch & Dr Shubs Upadhyay

NHS General Practitioners and Clinical Leads, Ada Health

Dr Harpreet Sood

Associate Chief Clinical Information Officer, NHS England

Mr Hetan Shah

Executive Director, Royal Statistical Society

Professor Mihaela van der Schaar

John Humphrey Plummer Professor of Machine Learning, AI and Medicine, University of Cambridge  

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Dr Sandy Wright, Trainee Representative, Digital Health Section, Royal Society of Medicine

Session one

Mr Charles Lowe, Council Member, Digital Health Section, Royal Society of Medicine

What is a research hospital?

Professor Geraint Rees, Dean, Faculty of Life Sciences, University College London

The macroeconomic ethics of the AI market in healthcare

Ms Eleonora Harwich, Director of Research, Reform

How deep learning could transform NHS breast screening

Dr Hugh Harvey, Clinical Director, Kheiron Medical Technologies

Panel discussion 

Professor Geraint Rees, Ms Eleonora Harwich and Dr Hugh Harvey

Tea and coffee break

Session two

Dr Michelle Tempest, Partner, Candesic

AI update from DeepMind

Dr Dominic King, Health Lead, DeepMind

Ethical and regulatory perspectives on AI in healthcare

Dr Matthew Fenech, Affiliate Consultant, AI in Health, Future Advocacy

AI in the operating theatre

Dr Jean Nehme, Co-Founder and Chief Executive Officer, Digital Surgery

Panel discussion

Dr Dominic King, Dr Matthew Fenech and Dr Jean Nehme

Lunch

Session three

Dr Tim Ringrose, Council Member, Digital Health Section, Royal Society of Medicine

Debate: Can AI improve general practice?

Dr Keith Grimes, Clinical Innovation Director, Babylon Health and Professor Martin Marshall, Vice Chair External Affairs, Royal College of General Practitioners

Artificial intelligence - From data to drugs

Dr Ian Churcher, Vice President, Drug Discovery, BenevolentAI

Tea and coffee break

Session four

Mr Alan Clarke, Immediate Past President, Digital Health Section, Royal Society of Medicine

Global healthcare challenge: Learnings and implications for AI

Dr Adel Baluch, NHS General Practitioner and Clinical Lead, Ada Health and Dr Shubs Upadhyay, NHS Urgent Care General Practitioner and Clinical Lead, Ada Health

Session five

Vivienne Parry, Head of Engagement, Genomics England

Panel Discussion - The Topol Review: Next Steps

Dr Harpreet Sood, Associate Chief Clinical Information Officer, NHS England, Mr Hetan Shah, Executive Director, Royal Statistical Society and Professor Mihaela van der Schaar, John Humphrey Plummer Professor of Machine Learning, AI and Medicine, University of Cambridge           

Closing remarks

Miss Dina Radenkovic, Trainee Representative, Digital Health Section, Royal Society of Medicine

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, London, W1G 0AE, United Kingdom

Other events of interest